scholarly journals Review of Clinical Effects and Presumed Mechanism of Action of the French Oak Wood Extract Robuvit

Author(s):  
Franziska Weichmann ◽  
Fabrice Avaltroni ◽  
Carolina Burki
Author(s):  
L.Ya. Fedorich

Objective — to study the modern classification, mechanisms of action and clinical effects of vitamin A derivatives, to analyze retinoid for local treatment of various dermatoses with a universal mechanism of action at the epidermis and dermis levels. Materials and methods. A review of the literature and an analysis of the results of international clinical trials of drugs based on the natural retinoid of the first generation — tretinoin (retinoic acid) is presented. The works of dozens of authors since 1980s to the present day are analyzed. Most sources provide detailed information on the results of topical retinoids in acne therapy, which are the base of clinical guidelines. Long-term (6 months or more) studies of retinoic acid-based preparations carried out in recent decades have discovered the unique clinical effects of tretinoin in the treatment of skin photoaging, actinic keratosis, etc. They are achieved due to the effect of tretinoid on the nuclear receptors of keratinocytes and fibroblasts. Results and discussion. The molecular mechanisms of action of retinoic acid, realizing the cellular and tissue effects of the most studied retinoid, are systematized and grouped in a single review. It has been proven that a unique feature of tretinin is its ability to activate directly all subtypes of RARs- and, indirectly, RARs-nuclear receptors of skin cells. A new modern drug for external use is presented — AltrenoТМ lotion containing micronized 0.05 % tretinoin in combination with sodium hyaluronate, soluble collagen and glycerin. This combination exhibits the expected clinical efficacy in acne therapy and prevents side effects such as dryness, redness and exfoliation. AltrenoТМ is approved for use in children of 9 years of age and older. Conclusions. Tretinoin (retinoic acid) is a modern powerful retinoid with a universal mechanism of action, recommended for the treatment of acne.


2020 ◽  
Vol 13 ◽  
pp. 175628481989753 ◽  
Author(s):  
William D. Chey ◽  
Eric D. Shah ◽  
Herbert L. DuPont

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with a multifactorial pathophysiology. The gut microbiota differs between patients with IBS and healthy individuals. After a bout of acute gastroenteritis, postinfection IBS may result in up to approximately 10% of those affected. Small intestinal bacterial overgrowth (SIBO) is more common in patients with IBS than in healthy individuals, and eradication of SIBO with systemic antibiotics has decreased symptoms of IBS in some patients with IBS and SIBO. The nonsystemic (i.e. low oral bioavailability) antibiotic rifaximin is indicated in the United States and Canada for the treatment of adults with IBS with diarrhea (IBS-D). The efficacy and safety of 2-week single and repeat courses of rifaximin have been demonstrated in randomized, placebo-controlled studies of adults with IBS. Rifaximin is widely thought to exert its beneficial clinical effects in IBS-D through manipulation of the gut microbiota. However, current studies indicate that rifaximin induces only modest effects on the gut microbiota of patients with IBS-D, suggesting that the efficacy of rifaximin may involve other mechanisms. Indeed, preclinical data reveal a potential role for rifaximin in the modulation of inflammatory cytokines and intestinal permeability, but these two findings have not yet been examined in the context of clinical studies. The mechanism of action of rifaximin in IBS is likely multifactorial, and further study is needed.


2020 ◽  
Vol 11 ◽  
Author(s):  
Linda Volpp ◽  
Vladimír Ferianec ◽  
Miriam Ježovičová ◽  
Zdeňka Ďuračková ◽  
Oliver Scherf-Clavel ◽  
...  
Keyword(s):  
Oak Wood ◽  

Author(s):  
Mohan Krishna Ghanta ◽  
Neha Merchant ◽  
L.V.K.S. Bhaskar

: Epilepsy responds to pharmacotherapy in its initial stages. The response of some forms of epilepsy like the refractory epilepsy is extremely low. Surgical management of epilepsy is associated with complications, which necessitates the search for novel and modern strategies for the treatment of epilepsy. Neuroprotection and neuronal regeneration are the major targets that must be accomplished by the new strategies. Hematopoietic stem cell (HSCs) therapy for epilepsy has shown promising results in pre-clinical studies with marginal clinical effects. This review explores the characteristics, mechanism of action, and clinical significance of HSCs therapy for the treatment of epilepsy.


Author(s):  
Christopher M. Duncan ◽  
Paula A. Craigo

Chapter 2 reviews the mechanism of action for local anesthetics. Clinical features such as potency, onset of action, duration, and dose are discussed. Drug metabolism, toxicity (local and systemic), and its treatment are included. The chapter concludes with additional information on adjuvant medications (eg, epinephrine, clonidine) used to extend or enhance the clinical effects of local anesthetics.


2015 ◽  
Vol 29 (8) ◽  
pp. 1219-1224 ◽  
Author(s):  
Zuzana Országhová ◽  
Iveta Waczulíková ◽  
Carolina Burki ◽  
Peter Rohdewald ◽  
Zdeňka Ďuračková

Sign in / Sign up

Export Citation Format

Share Document